» Authors » Sirpi Nackeeran

Sirpi Nackeeran

Explore the profile of Sirpi Nackeeran including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 45
Citations 192
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Golan R, McGovern A, Shin Y, Rojanasarot S, Kohn T, Nackeeran S, et al.
Am J Mens Health . 2024 Oct; 18(5):15579883241290714. PMID: 39432418
We evaluated depression-related health care resource utilization and antidepressant prescription medication utilization among commercially insured men in the United States who underwent inflatable penile prosthesis (IPP) implantation between January 1,...
2.
Nackeeran S, Ramasamy R
Int J Impot Res . 2024 May; 36(5):543-544. PMID: 38796560
No abstract available.
3.
Zucker I, Nackeeran S, Mirza S, Masterson T
Urology . 2023 Nov; 183:117-120. PMID: 37949243
Objective: To evaluate risk factors leading to corporal rupture after Collagenase Clostridium histolyticum (CCh). Peyronie's disease (PD) is a fibrotic condition of the penis characterized by abnormal plaque formation. Intralesional...
4.
Suarez Arbelaez M, Khanna K, Raymo A, Weber A, Lerendegui L, Nackeeran S, et al.
J Pediatr Urol . 2023 Oct; 20(1):76.e1-76.e7. PMID: 37839944
Introduction: The role of voiding cystourethrogram (VCUG) in evaluating vesicoureteral reflux (VUR) in patients with known ureteropelvic junction obstruction (UPJO) remains unclear. While VCUG is frequently performed, the incidence of...
5.
Nackeeran S, Ramasamy R
Eur Urol . 2023 Oct; 85(2):181. PMID: 37802684
No abstract available.
6.
Suarez Arbelaez M, Nackeeran S, Shah K, Blachman-Braun R, Bronson I, Towe M, et al.
Ann Med . 2023 Apr; 55(1):2197293. PMID: 37036830
Introduction: The study aims to determine whether body mass index (BMI), metabolic syndrome (MS) or its individual components (primary hypertension, type 2 diabetes mellitus and dyslipidemias) are risk factors for...
7.
Kresch E, Lima T, Molina M, Deebel N, Reddy R, Patel M, et al.
Sex Med . 2023 Mar; 11(2):qfad007. PMID: 36936900
Background: Testosterone deficiency (TD) is a prevalent condition, especially in men ≥45 years old, and testosterone therapy (TTh) can improve the quality of life in these patients. Aim: To evaluate...
8.
Katz J, Abdelrahman L, Nackeeran S, Ezeh U, Visser U, Deane L
Urology . 2023 Feb; 174:58-63. PMID: 36736916
Objective: To improve upon prior attempts to predict which patients will pass their obstructing ureteral stones, we developed a machine learning algorithm to predict the passage of obstructing ureteral stones...
9.
Delgado J, Ory J, Loloi J, Deebel N, Bernstein A, Nackeeran S, et al.
Cureus . 2023 Jan; 14(12):e32699. PMID: 36686106
Introduction Many men receiving temporary androgen deprivation therapy (ADT) for localized prostate cancer fail to achieve baseline testosterone levels after cessation. Testosterone recovery in men with localized prostate cancer receiving...
10.
Nackeeran S
Fertil Steril . 2023 Jan; 119(3):409. PMID: 36621708
No abstract available.